Divi's Laboratories Limited (DIVISLAB) — Board Meeting | 6 August 2025(2 announcements)

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Board Meeting 🟡 Notable Neutral 📄 PDF

Divi's Laboratories Limited board amended its Policy on Determination of Materiality Disclosure of Events or Information on August 6, 2025. The amendment updated designated officials responsible for determining materiality and disclosing material events to stock exchanges. Key contacts include Managing Director Dr. Murali K. Divi, CEO Dr. Kiran S. Divi, and CFO Venkatesa Perumallu Pasumarthy, with disclosure authority assigned to the CFO and Company Secretary.

2 Board Meeting 🟡 Notable ✨ Positive 📄 PDF

Divi's Laboratories reported Q1 FY2025-26 consolidated total income of ₹2,529 crores versus ₹2,197 crores YoY (15% growth), with profit before tax of ₹733 crores versus ₹604 crores YoY. Consolidated net profit reached ₹545 crores compared to ₹430 crores in the prior-year quarter. Forex gains contributed ₹39 crores versus a ₹1 crore loss previously. On standalone basis, total income was ₹2,476 crores and PAT was ₹557 crores.

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

📡 Get AI alerts when DIVISLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DIVISLAB — Free

📊 More DIVISLAB filings

See all DIVISLAB filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DIVISLAB files new disclosures

Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track DIVISLAB — Free

Free account · 2 AI queries/day